• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于多种短发夹RNA表达及持久抑制HIV-1的慢病毒载体设计

Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.

作者信息

ter Brake Olivier, 't Hooft Karen, Liu Ying Poi, Centlivre Mireille, von Eije Karin Jasmijn, Berkhout Ben

机构信息

Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Mol Ther. 2008 Mar;16(3):557-64. doi: 10.1038/sj.mt.6300382. Epub 2008 Jan 15.

DOI:10.1038/sj.mt.6300382
PMID:18180777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7172400/
Abstract

Human immunodeficiency virus type 1 (HIV-1) replication in T cells can be inhibited by RNA interference (RNAi) through short hairpin RNA (shRNA) expression from a lentiviral vector. However, for the development of a durable RNAi-based gene therapy against HIV-1, multiple shRNAs need to be expressed simultaneously in order to avoid viral escape. In this study, we tested a multiple shRNA expression strategy for different shRNAs using repeated promoters in a lentiviral vector. Although highly effective in co-transfection experiments, a markedly reduced activity of each expressed shRNA was observed in transduced cells. We found that this reduced activity was due to recombination of the expression cassette repeat sequences during the transduction of the lentiviral vector, which resulted in deletions of one or multiple cassettes. To avoid recombination, we tested different promoters for multiple shRNA expression. We compared the activity of the human polymerase III promoters U6, H1, and 7SK and the polymerase II U1 promoter. Activities of these promoters were similar, irrespective of which shRNA was expressed. We showed that these four expression cassettes can be combined in a single lentiviral vector without causing recombination. Moreover, whereas HIV-1 could escape from a single shRNA, we now show that HIV-1 escape can be prevented when four shRNAs are simultaneously expressed in a cell.

摘要

1型人类免疫缺陷病毒(HIV-1)在T细胞中的复制可通过慢病毒载体表达短发夹RNA(shRNA),利用RNA干扰(RNAi)来抑制。然而,要开发一种持久的基于RNAi的抗HIV-1基因疗法,需要同时表达多个shRNA以避免病毒逃逸。在本研究中,我们在慢病毒载体中使用重复启动子测试了针对不同shRNA的多shRNA表达策略。尽管在共转染实验中非常有效,但在转导细胞中观察到每个表达的shRNA活性明显降低。我们发现这种活性降低是由于慢病毒载体转导过程中表达盒重复序列的重组,导致一个或多个盒的缺失。为避免重组,我们测试了用于多shRNA表达的不同启动子。我们比较了人类聚合酶III启动子U6、H1和7SK以及聚合酶II U1启动子的活性。这些启动子的活性相似,与所表达的shRNA无关。我们表明这四个表达盒可以组合在单个慢病毒载体中而不引起重组。此外,虽然HIV-1可以从单个shRNA逃逸,但我们现在表明当在细胞中同时表达四个shRNA时可以防止HIV-1逃逸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/cd82d10a5a2a/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/7b0fc5f0e37d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/8e3ab1406a69/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/aa0d28c6d2c2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/cfd4114abb80/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/f11c6d44a1c6/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/e35c7408db7a/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/cd82d10a5a2a/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/7b0fc5f0e37d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/8e3ab1406a69/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/aa0d28c6d2c2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/cfd4114abb80/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/f11c6d44a1c6/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/e35c7408db7a/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c9/7172400/cd82d10a5a2a/gr7_lrg.jpg

相似文献

1
Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.用于多种短发夹RNA表达及持久抑制HIV-1的慢病毒载体设计
Mol Ther. 2008 Mar;16(3):557-64. doi: 10.1038/sj.mt.6300382. Epub 2008 Jan 15.
2
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition.用于多种shRNA表达和持久抑制HIV-1的慢病毒载体设计
Mol Ther. 2008 Mar;16(3):557-564. doi: 10.1038/sj.mt.6300382. Epub 2016 Dec 8.
3
Silencing of HIV-1 with RNA interference: a multiple shRNA approach.利用RNA干扰沉默HIV-1:一种多短发夹RNA方法。
Mol Ther. 2006 Dec;14(6):883-92. doi: 10.1016/j.ymthe.2006.07.007. Epub 2006 Sep 7.
4
Expression of Duplex shRNAs through a Lentiviral Vector against Cellular and Viral Genes Inflicts Sustained Inhibition of Hepatitis C Virus Replication.通过慢病毒载体表达针对细胞和病毒基因的双链短发夹 RNA 可持续抑制丙型肝炎病毒复制。
Intervirology. 2018;61(2):79-91. doi: 10.1159/000492220. Epub 2018 Sep 25.
5
Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells.基于慢病毒载体的小发夹RNA表达可在包括原代非分裂细胞在内的人类细胞上有效且稳定地抑制HIV-1基因。
Microbes Infect. 2004 Jan;6(1):76-85. doi: 10.1016/j.micinf.2003.10.009.
6
Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.携带抗HIV短发夹RNA的慢病毒载体:问题与解决方案
J Gene Med. 2007 Sep;9(9):743-50. doi: 10.1002/jgm.1078.
7
DNA vector-based RNA interference to study gene function in cancer.基于DNA载体的RNA干扰技术在癌症基因功能研究中的应用
J Vis Exp. 2012 Jun 4(64):e4129. doi: 10.3791/4129.
8
Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.一种具有新型Tat诱导表达系统及对靶细胞特异性嗜性的慢病毒载体对HIV-1的抑制作用
Hum Gene Ther. 2015 Oct;26(10):680-7. doi: 10.1089/hum.2015.031. Epub 2015 Aug 6.
9
The impact of unprotected T cells in RNAi-based gene therapy for HIV-AIDS.RNAi 基因治疗艾滋病中未受保护 T 细胞的影响。
Mol Ther. 2014 Mar;22(3):596-606. doi: 10.1038/mt.2013.280. Epub 2013 Dec 12.
10
Identification and comparison of the porcine H1, U6, and 7SK RNA polymerase III promoters for short hairpin RNA expression.鉴定和比较猪 H1、U6 和 7SK RNA 聚合酶 III 启动子用于短发夹 RNA 表达。
Mamm Genome. 2020 Apr;31(3-4):110-116. doi: 10.1007/s00335-020-09838-0. Epub 2020 Apr 21.

引用本文的文献

1
Engineered mouse H1 promoter mutants with superior RNA polymerase III activity.具有卓越RNA聚合酶III活性的工程化小鼠H1启动子突变体。
Biochem Biophys Rep. 2024 Jul 30;39:101795. doi: 10.1016/j.bbrep.2024.101795. eCollection 2024 Sep.
2
Application of CHyMErA Cas9-Cas12a combinatorial genome-editing platform for genetic interaction mapping and gene fragment deletion screening.CHyMErA Cas9-Cas12a 组合基因组编辑平台在遗传互作作图和基因片段缺失筛选中的应用。
Nat Protoc. 2021 Oct;16(10):4722-4765. doi: 10.1038/s41596-021-00595-1. Epub 2021 Sep 10.
3
Dual sgRNA-based Targeted Deletion of Large Genomic Regions and Isolation of Heritable Mutants in .

本文引用的文献

1
A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs.一种通过RNA干扰抑制HIV-1的新方法:用第二代小干扰RNA对抗病毒逃逸
J RNAi Gene Silencing. 2005 Oct 14;1(2):56-65.
2
Design of extended short hairpin RNAs for HIV-1 inhibition.用于抑制HIV-1的延长型短发夹RNA的设计
Nucleic Acids Res. 2007;35(17):5683-93. doi: 10.1093/nar/gkm596. Epub 2007 Aug 21.
3
Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC.
基于双sgRNA的大基因组区域靶向缺失及可遗传突变体的分离 于……(此处原文未完整给出具体情境)
Bio Protoc. 2020 Oct 20;10(20):e3796. doi: 10.21769/BioProtoc.3796.
4
A novel treatment approach for retinoblastoma by targeting epithelial growth factor receptor expression with a shRNA lentiviral system.一种通过使用短发夹RNA慢病毒系统靶向上皮生长因子受体表达来治疗视网膜母细胞瘤的新方法。
Iran J Basic Med Sci. 2017 Jul;20(7):739-744. doi: 10.22038/IJBMS.2017.9003.
5
Mutation of nucleotides around the +1 position of type 3 polymerase III promoters: The effect on transcriptional activity and start site usage.3型聚合酶III启动子+1位置周围核苷酸的突变:对转录活性和起始位点使用的影响。
Transcription. 2017;8(5):275-287. doi: 10.1080/21541264.2017.1322170. Epub 2017 Jun 9.
6
E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.E6和E7基因沉默导致肿瘤抑制基因甲基化减少,并诱导人宫颈癌细胞系的表型转化。
Oncotarget. 2015 Sep 15;6(27):23930-43. doi: 10.18632/oncotarget.4525.
7
The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy.HIV-1 基因多样性对组合 RNAi 基因为基础的基因治疗功效的影响。
Gene Ther. 2015 Jun;22(6):485-95. doi: 10.1038/gt.2015.11. Epub 2015 Feb 26.
8
A novel approach to block HIV-1 coreceptor CXCR4 in non-toxic manner.一种以无毒方式阻断HIV-1共受体CXCR4的新方法。
Mol Biotechnol. 2014 Oct;56(10):890-902. doi: 10.1007/s12033-014-9768-7.
9
Selection of RNAi-based inhibitors for anti-HIV gene therapy.用于抗HIV基因治疗的基于RNA干扰的抑制剂的选择。
World J Virol. 2012 Jun 12;1(3):79-90. doi: 10.5501/wjv.v1.i3.79.
10
Efficient viral delivery system for unnatural amino acid mutagenesis in mammalian cells.高效病毒传递系统在哺乳动物细胞中进行非天然氨基酸诱变。
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11803-8. doi: 10.1073/pnas.1309584110. Epub 2013 Jul 1.
小干扰RNA的组合递送通过选择性掺入RNA诱导沉默复合体(RISC)而降低RNA干扰(RNAi)功效。
Nucleic Acids Res. 2007;35(15):5154-64. doi: 10.1093/nar/gkm543. Epub 2007 Jul 26.
4
Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.携带抗HIV短发夹RNA的慢病毒载体:问题与解决方案
J Gene Med. 2007 Sep;9(9):743-50. doi: 10.1002/jgm.1078.
5
Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cells.含有三种抗HIV基因(CCR5核酶、tat-rev小干扰RNA和TAR诱饵)的慢病毒载体在严重联合免疫缺陷-人源化小鼠衍生T细胞中的安全性和有效性。
Mol Ther. 2007 Jun;15(6):1182-8. doi: 10.1038/sj.mt.6300157. Epub 2007 Apr 3.
6
Combinatorial RNAi: a winning strategy for the race against evolving targets?组合RNA干扰:对抗不断进化的靶点的制胜策略?
Mol Ther. 2007 May;15(5):878-88. doi: 10.1038/sj.mt.6300116. Epub 2007 Feb 20.
7
Gene transfer in humans using a conditionally replicating lentiviral vector.使用条件性复制慢病毒载体进行人类基因转移。
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17372-7. doi: 10.1073/pnas.0608138103. Epub 2006 Nov 7.
8
HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.人源化Rag2-/-γc-/-(RAG-hu)小鼠模型中的HIV-1感染与CD4 T细胞耗竭
Retrovirology. 2006 Nov 1;3:76. doi: 10.1186/1742-4690-3-76.
9
The lifetime cost of current human immunodeficiency virus care in the United States.美国目前人类免疫缺陷病毒治疗的终身成本。
Med Care. 2006 Nov;44(11):990-7. doi: 10.1097/01.mlr.0000228021.89490.2a.
10
An essential role for LEDGF/p75 in HIV integration.LEDGF/p75在HIV整合中的重要作用。
Science. 2006 Oct 20;314(5798):461-4. doi: 10.1126/science.1132319. Epub 2006 Sep 7.